Table 2.
Anthropometric Measures at Week 0 and Week 16
| Measurement | Week | MD Group Mean ± SD |
Within Group Δ p-value |
Week | FB Group Mean ± SD |
Within Group Δ p-value |
Between Group Δ p-value |
|---|---|---|---|---|---|---|---|
| Weight (kgs)* | 0 (n = 45) | 111.6 ± 25.7 | p < 0.0001 | 0 (n = 45) | 104.1 ± 17.1 | p < 0.0001 | p = 0.001 |
| 16 (n = 28) | 98.0 ± 23.9 | 16 (n = 20) | 95.4 ± 18.9 | ||||
| BMI (kg/m2) | 0 (n = 45) | 38.5 ± 6.8 | p < 0.0001 | 0 (n = 45) | 37.8 ± 4.5 | p = 0.001 | p = 0.001 |
| 16 (n = 28) | 33.8 ± 6.6 | 16 (n = 20) | 34.7 ± 5.9 | ||||
| Waist | 0 (n = 45) | 116.6 ± 15.5 | p < 0.0001 | 0 (n = 45) | 114.2 ± 15.0 | p = 0.003 | p = 0.028 |
| Circumference (cm) | 16 (n = 26) | 104.5 ± 16.9 | 16 (n = 20) | 104.9 ± 14.9 | |||
| Body Fat (%)* | 0 (n = 45) | 42.8 ± 7.7 | p < 0.0001 | 0(n = 45) | 44.1 ± 6.4 | p = 0.268 | p < 0.0001 |
| 16 (n = 27) | 37.5 ± 8.8 | 16 (n = 20) | 41.0 ± 7.6 | ||||
| Lean Muscle | 0 (n = 41) | 56.8 ± 11.4 | p < 0.0001 | 0 (n = 41) | 53.3 ± 8.7 | p = 0.003 | p = 0.56 |
| Mass (kgs) | 16 (n = 25) | 55.0 ± 10.4 | 16 (n = 20) | 52.8 ± 9.4 | |||
| Visceral Fat | 0 (n = 41) | 13.8 ± 3.8 | p < 0.0001 | 0 (n = 41) | 13.7 ± 5.0 | p = 0.081 | p < 0.0001 |
| Rating | 16 (n = 25) | 10.6 ± 3.5 | 16 (n = 20) | 14.2 ± 6.1 | |||
| Systolic BP | 0 (n = 45) | 125.4 ± 13.9 | p < 0.0001 | 0 (n = 45) | 125.8 ± 13.6 | p = 0.003 | p = 0.667 |
| (mmHg) | 16 (n = 28) | 113.6 ± 14.3 | 16 (n = 20) | 115.8 ± 12.3 | |||
| Diastolic BP | 0 (n = 45) | 83.2 ± 9.5 | p = 0.001 | 0 (n = 45) | 82.6 ± 10.2 | p = 0.016 | p = 0.622 |
| (mmHg) | 16 (n = 28) | 74.2 ± 8.8 | 16 (n = 20) | 74.2 ± 6.8 | |||
| Pulse, | 0 (n = 45) | 76.4 ± 9.3 | p = 0.001 | 0 (n = 45) | 73.9 ± 9.2 | p = 0.011 | p = 0.112 |
| (bpm) | 16 (n = 26) | 67.2 ± 8.6 | 16 (n = 19) | 71.2 ± 8.1 |
Δ = Change from baseline to 16 weeks.
* = Primary outcomes. All others are secondary outcomes.